Skip to content
6-K

Foreign Interim / Material

Galmed Pharmaceuticals Ltd. GLMD

0001493152-25-025070

← back to feed
Filed
Nov 26, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 5.46M sh
Shares Diluted Q3 2025 · Sep 30, 2025 3.74M sh
Shares Diluted Q3 2025 · Sep 30, 2024 829.5K sh
Shares Diluted Q3 2025 · Sep 30, 2024 705.43K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$4.37M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$3.97M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $3.31M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $4.65M
Stockholders Equity Q3 2025 · Sep 30, 2025 $19.11M
Stockholders Equity Q3 2025 · Jun 30, 2025 $20.52M
Stockholders Equity Q3 2025 · Dec 31, 2024 $16.33M
Stockholders Equity Q3 2025 · Sep 30, 2024 $18.44M
Stockholders Equity Q3 2025 · Jun 30, 2024 $11.79M
Stockholders Equity Q3 2025 · Dec 31, 2023 $13.88M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.47M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.17M
Current Assets Q3 2025 · Sep 30, 2025 $19.72M
Current Assets Q3 2025 · Dec 31, 2024 $16.12M
Total Assets Q3 2025 · Sep 30, 2025 $21.58M
Total Assets Q3 2025 · Dec 31, 2024 $18.5M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.33
Eps Diluted Q3 2025 · Sep 30, 2025 $1.47
Eps Diluted Q3 2025 · Sep 30, 2024 $2.31
Eps Diluted Q3 2025 · Sep 30, 2024 $6.11
Eps Basic Q3 2025 · Sep 30, 2025 $0.33
Eps Basic Q3 2025 · Sep 30, 2025 $1.47
Eps Basic Q3 2025 · Sep 30, 2024 $2.31
Eps Basic Q3 2025 · Sep 30, 2024 $6.11
Sga Expense Q3 2025 · Sep 30, 2025 $1.01M
Sga Expense Q3 2025 · Sep 30, 2025 $2.69M
Sga Expense Q3 2025 · Sep 30, 2024 $1.27M
Sga Expense Q3 2025 · Sep 30, 2024 $2.73M
Rd Expense Q3 2025 · Sep 30, 2025 $1.09M
Rd Expense Q3 2025 · Sep 30, 2025 $2.78M
Rd Expense Q3 2025 · Sep 30, 2024 $738K
Rd Expense Q3 2025 · Sep 30, 2024 $1.91M
Net Income Q3 2025 · Sep 30, 2025 −$1.89M
Net Income Q3 2025 · Sep 30, 2025 −$5.49M
Net Income Q3 2025 · Jun 30, 2025 −$3.6M
Net Income Q3 2025 · Sep 30, 2024 −$1.91M
Net Income Q3 2025 · Sep 30, 2024 −$4.31M
Net Income Q3 2025 · Jun 30, 2024 −$2.39M
Stock Issued Q3 2025 · Aug 26, 2025 12.5K sh
Stock Issued Q3 2025 · Nov 12, 2024 17.5K sh
Stock Issued Q3 2025 · Aug 30, 2024 31.57K sh
Stock Issued Q3 2025 · Jul 18, 2023 31.67K sh